Prof. Dr. Christoph Mundhenke



close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Head-to-head comparison of the impact of Aurora A, Aurora B, Repp86, CDK1, CDK2 and Ki67 expression in two of the most relevant gynaecological tumor entities (2016) Heilmann T, Dittmann L, Van Mackelenbergh M, Mundhenke C, Weimer J, Arnold N, Maass N, Schem C Journal article Stromal markers AKR1C1 and AKR1C2 are prognostic factors in primary human breast cancer (2016) Wenners A, Hartmann F, Jochens A, Roemer AM, Alkatout I, Klapper W, Van Mackelenbergh M, et al. Journal article Impact of Histopathological Factors, Patient History and Therapeutic Variables on Recurrence-free Survival after Ductal Carcinoma in Situ: 8-Year Follow-up and Questionnaire Survey (2016) Van Mackelenbergh MT, Lindner CM, Heilmann T, Alkatout I, Elessawy M, Mundhenke C, Maass N, Schem C Journal article, Review article Factors Influencing Decision-Making for or against Adjuvant and Neoadjuvant Chemotherapy in Postmenopausal Hormone Receptor-Positive Breast Cancer Patients in the EvAluate-TM Study (2016) Gaß P, Fasching P, Fehm T, De Waal J, Rezai M, Baier B, Baake G, et al. Journal article Prognostic factors in gynecological tumors and breast cancer Prognosefaktoren gynäkologischer Malignome (2015) v. Mackelenbergh MT, Mundhenke C Journal article Clinical implications of first and multiple locoregional breast cancer recurrences (2015) Wenners A, Berlin L, Alkatout I, Van Mackelenbergh M, Jonat W, Mundhenke C Journal article Vulvar cancer: Epidemiology, clinical presentation, and management options (2015) Alkatout I, Schubert M, Garbrecht N, Weigel MT, Jonat W, Mundhenke C, Günther V Journal article Final safety and efficacy analysis of a phase I/II trial with imatinib and vinorelbine for patients with metastatic breast cancer (2014) Maass N, Schem C, Bauerschlag DO, Tiemann K, Schaefer FW, Hanson S, Muth M, et al. Journal article Nilotinib in combination with carboplatin and paclitaxel is a candidate for ovarian cancer treatment (2014) Weigel MT, Rath K, Alkatout I, Wenners AS, Schem C, Maass N, Jonat W, Mundhenke C Journal article Significance of syndecan-1 expression in ductal carcinoma In Situ of the breast (2014) Tiemann K, Weigel MT, Alkatout I, Wenners AS, Mundhenke H, Schäfer FW, Bauer M, et al. Journal article